COG — Cambridge Cognition Holdings Share News
0.000.00%
- £18.19m
- £19.24m
- £10.34m
REG - Cambridge Cognition - Electronic Clinical Outcomes Assessment Contract
AnnouncementREG - Cambridge Cognition - £1.0m Schizophrenia clinical trial contract
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Grant of Options
AnnouncementREG - Cambridge Cognition - Directorate Change
AnnouncementREG - Cambridge Cognition - Contract for pivotal schizophrenia clinical trial
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementREG - Cambridge Cognition - Trading Update and Notice of Results
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - £1 million contract for late phase cancer trial
AnnouncementREG - Cambridge Cognition - Spin-out of Monument Therapeutics
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
Announcement